Watch til the End!!This video is nothing compared to what else we got. in this one our buddy hair goes mental with a fan blade he just broke. In elevated reality its all real and all madness you will see in the future exactly what i mean..Hair loves
Genre: Funny Videos
by: Poopynugga
Tonya from San Francisco, CA
Genre: Entertainment
by: elevated
Security at the ESPN headquarters has been elevated.
by: bmacbud
3 bongs, aqualung, and a vapor bag...= paranoia and munchies.. good times
N.ew E.levated R.esoucres D.oubling S.ecurity
by: ie8videos
While investigating the second floor of the Waverly Hills Sanatorium we encountered some elevated EMF readings that could not be explained.
by: NAPIGhostHunters
At a recent Christian concert called Creation, the band Newsboys performed this incredible drums stunt on elevated platforms
by: yo_kid
This Euro Styling Home theater chair is an enormous fresh seating option for a Home theatre movie or your movie home theater. SeatsAndChairs.com has provided elevated superiority theater seats and installation for school auditoriums, community theaters, government facilities, and performing arts centers for more than 20 years. We have the perfect theater seating for you, whether you need new movie seats, refurbished, or used chairs.
Genre: News Videos
by: theaterseating
The U.S. Armys Joint Land Attack Cruise Missile Defense Elevated Sensor (JLENS) System, which uses aerostats to elevate sensors for long-range target detection and tracking for superior land-attack cruise missile defense, demonstrated its first flight today during a ceremony in Elizabeth City, N.C.To view Multimedia News Release, go to http://www.prnewswire.com/mnr/raytheon/39805/
by: comments
JUPITER, which used CRESTOR 20 mg, is the first statin study to demonstrate a reduction in the risk of cardiovascular (CV) events in women without established cardiovascular disease (CVD). In this new analysis of 6,801 women from the JUPITER study, rosuvastatin 20 mg reduced CV events by 46% in women without CVD but at increased risk of a cardiovascular event, as identified by age and elevated hsCRP (p=0.002 vs placebo). This analysis also showed a 42% reduction in CV events for men without established CVD (p is less than 0.001 vs placebo). These data were presented today at the American Heart Association Annual Scientific Sessions in Orlando, Florida.To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/astrazeneca/41126/
